SAGIMET BIOSCIENCES INC. Share Price Today: Live Updates & Key Insights

SAGIMET BIOSCIENCES INC. share price today is $4.83, up -0.21%. The stock opened at $4.86 against the previous close of $4.83, with an intraday high of $5.02 and low of $4.79.

SAGIMET BIOSCIENCES INC. Share Price Chart

SAGIMET BIOSCIENCES INC.

us-stock
To Invest in {{usstockname}}
us-stock

SAGIMET BIOSCIENCES INC. Share Price Performance

$4.83 -0.0021(-0.21%) SGMT at 23 Mar 2026 03:11 PM Biotechnology
Lowest Today 4.79
Highest Today 5.02
Today’s Open 4.86
Prev. Close 4.83
52 Week High 11.41
52 Week Low 1.73
Day’s Range: Low 4.79 High 5.02
52-Week Range: Low 1.73 High 11.41
1 day return -
1 Week return -6.23
1 month return -8.55
3 month return -22.91
6 month return -29.67
1 year return +16.74
3 year return -70.03
5 year return -
10 year return -

SAGIMET BIOSCIENCES INC. Institutional Holdings

SAGIMET BIOSCIENCES INC. Market Status

Strong Buy: 5

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

SAGIMET BIOSCIENCES INC. Fundamentals

Market Cap 157.06 M

PB Ratio 1.413

PE Ratio 0.0

Enterprise Value 44.34 M

Total Assets 116.48 M

Volume 370255

SAGIMET BIOSCIENCES INC. Company Financials

Annual Revenue FY23:2000000 2.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-26920000 -26.9M, FY22:-30499000 -30.5M, FY21:-24442000 -24.4M, FY20:-11370000 -11.4M, FY19:-14261000 -14.3M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-12908000 -12.9M, Q2/2025:-10386000 -10.4M, Q1/2025:-18176000 -18.2M, Q3/2024:-14619000 -14.6M, Q2/2024:-8118000 -8.1M

About SAGIMET BIOSCIENCES INC. & investment objective

Company Information Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis, acne, and select forms of cancer. It also develops TVB-3567, a FASN inhibitor for the treatment of acne indication; and other oncology programs, such as solid tumor and glioblastoma. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.

Organisation Biotechnology

Employees 16

Industry Biotechnology

CEO Mr. David A. Happel

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

SAGIMET BIOSCIENCES INC. FAQs

What is the share price of SAGIMET BIOSCIENCES INC. today?

The current share price of SAGIMET BIOSCIENCES INC. is $4.83.

Can I buy SAGIMET BIOSCIENCES INC. shares in India?

Yes, Indian investors can buy SAGIMET BIOSCIENCES INC. shares by opening an international trading and demat account with Motilal Oswal.

How to buy SAGIMET BIOSCIENCES INC. shares in India?

You can easily invest in SAGIMET BIOSCIENCES INC. shares from India by:

Can I buy fractional shares of SAGIMET BIOSCIENCES INC.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of SAGIMET BIOSCIENCES INC.?

SAGIMET BIOSCIENCES INC. has a market cap of $157.06 M.

In which sector does SAGIMET BIOSCIENCES INC. belong?

SAGIMET BIOSCIENCES INC. operates in the Biotechnology sector.

What documents are required to invest in SAGIMET BIOSCIENCES INC. stocks?

To invest, you typically need:

What is the PE and PB ratio of SAGIMET BIOSCIENCES INC.?

The PE ratio of SAGIMET BIOSCIENCES INC. is N/A and the PB ratio is 1.41.